KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,390,233 | -37.9% | 113,674 | -37.0% | 0.12% | -32.4% |
| Q4 2022 | $2,240,005 | -24.9% | 180,500 | -17.3% | 0.18% | -29.2% |
| Q3 2022 | $2,983,000 | -30.5% | 218,366 | -6.8% | 0.25% | -30.3% |
| Q2 2022 | $4,294,000 | +13.9% | 234,273 | -0.0% | 0.36% | +22.6% |
| Q1 2022 | $3,769,000 | +23.2% | 234,372 | +7.3% | 0.30% | +51.8% |
| Q4 2021 | $3,059,000 | -18.3% | 218,497 | +9.2% | 0.20% | -16.3% |
| Q3 2021 | $3,746,000 | +27.1% | 200,015 | +41.5% | 0.23% | +56.4% |
| Q2 2021 | $2,947,000 | -0.0% | 141,346 | +35.5% | 0.15% | -24.0% |
| Q1 2021 | $2,948,000 | – | 104,293 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |